A special holiday in the Beijing region kept 11.7 million vehicles off the road and closed 10,000 factories while the Asia-Pacific Economic Cooperation summit was in session
Midway through Manchester United's second consecutive terrible season, revenue at the storied soccer club is sliding and share prices are sinking.
Crimea, the former Ukrainian peninsula annexed by Russia, is now witnessing a wave of nationalizations
Tesla is making more cars, but fewer of them are ending up registered to U.S. drivers
The provider of high-interest business loans nears an IPO, on the strength of its data-powered credit analysis—and a network of shady brokers
Would the debate make more sense if net neutrality had a different moniker?
The Newark (N.J.) airport will accept United frequent-flyer miles as payment, a further evolution in making miles a real currency
Lucky fans got to spend two hours cooking Thanksgiving dinner with the Jets quarterback
Twenty years after Dumb and Dumber came out, thousands of entrepreneurs make a living driving tricked-out pet-care vans
Founders: Dr. Mark Chandler and Craig Benson (The company was formed in 1998 as a wholly owned subsidiary of Luminex Corp. (LMNX) and subsequently spun off in 2002 as a private management-owned entity.)
VC Investment over the last four quarters: $25 million
With 95 employees worldwide, Rules-Based Medicine, a biomarker testing company, is actively developing diagnostic tests to detect the presence of complex diseases and conditions in the areas of neuropsychiatry, nephrology, immunology, and cardiology. The company is also developing what it calls the first fully closed reproducible whole-blood culture system. Despite the recession, Rules-Based Medicine's founders remain optimistic about its prospects and those of its peers that promote efficiency and cost savings for drug development and diagnostics customers.
Key to startup success: "We took a customer-focused approach to biotechnology, which drove our decision to commit resources to developing much needed comprehensive biomarker content. ... Our customers have essentially directed and funded our R&D since inception."